Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37141665)
Watch
English
Advanced gastric cancer: an update and future directions
scientific article published on July 2008
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
title
Advanced gastric cancer: an update and future directions
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
author name string
Al B Benson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
publication date
1 July 2008
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
published in
Gastrointestinal cancer research : GCR
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
volume
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
issue
4 Suppl
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
page(s)
S47-53
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
cites work
Chemotherapy for advanced gastric cancer: review of global and Japanese status.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
6 September 2017
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
14 September 2017
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
14 September 2017
Emerging molecular targets in esophageal cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
27 June 2018
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
27 June 2018
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
3 September 2018
Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
3 September 2018
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
3 September 2018
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
3 September 2018
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2661550
retrieved
3 September 2018
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19343150
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime?
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19343150
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19343150
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19343150
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/19343150
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
PMC publication ID
2661550
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
PubMed publication ID
19343150
1 reference
stated in
Europe PubMed Central
PMC publication ID
2661550
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19343150%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
